Coherus BioSciences, Inc.'s latest quarterly earnings per share is $ with a past EPS surprise of $ The latest EPS estimate is $ Read more about. Data delayed at least 15 minutes, as of Aug 30 BST. Use our equities screener to discover other potential opportunities. Find Similar Stocks. Coherus BioSciences, Inc. (US:CHRS) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission . (“Coherus”, Nasdaq: CHRS) today announced the pricing of its underwritten public offering of 11,, shares of its common stock at a price to the public of. Get the latest updates on Coherus BioSciences, Inc. Common Stock (CHRS) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Get Coherus BioSciences Inc (CHRS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Stock analysis for Coherus Biosciences Inc (CHRS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. Recent News · Coherus BioSciences downgraded to hold from buy at Maxim Group · Coherus BioSciences stock price target cut to $12 from $20 at Truist · Intuitive. CHRS - Coherus Biosciences Inc - Stock screener for investors and traders, financial visualizations. Coherus Biosciences (CHRS) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. The closing price, day's high, day's low, and day's volume have been adjusted to account for any stock splits and/or dividends. Stock information for Coherus BioSciences, Inc., a commercial-stage biopharmacetucial company developing a pipeline of novel immuno-oncology therapies. See the latest Coherus BioSciences Inc stock price (CHRS:XNAS), related news, valuation, dividends and more to help you make your investing decisions. View live Coherus BioSciences, Inc. chart to track its stock's price action. Find market predictions, CHRS financials and market news. Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and.
The latest Coherus BioSciences stock prices, stock quotes, news, and CHRS history to help you invest and trade smarter. Coherus is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of novel immunotherapies to treat cancer. Coherus BioSciences Inc. ; Volume, M ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Coherus BioSciences, Inc. (1pobeda.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Coherus BioSciences. Discover real-time Coherus BioSciences, Inc. Common Stock (CHRS) stock prices, quotes, historical data, news, and Insights for informed trading and. Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates. Coherus BioSciences (CHRS) delivered earnings and revenue surprises of % and %. The Investor Relations website contains information about Coherus BioSciences, Inc.'s business for stockholders, potential investors, and financial.
Coherus Biosciences (CHRS) Stock Price Performance. License Error: Access from crawling bot. Coherus Biosciences (CHRS) Stock Key Data. SummaryAdditional Data. Coherus BioSciences Inc CHRS:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/01/23 · 52 Week Low View today's Coherus BioSciences Inc stock price and latest CHRS news and analysis. Create real-time notifications to follow any changes in the live stock. View live Coherus BioSciences, Inc. chart to track its stock's price action. Find market predictions, CHRS financials and market news. Get Coherus BioSciences Inc (CHRS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Coherus Biosciences stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Previous Close. ; Average Volume. M ; Market Cap. M ; Shares Outstanding. M ; EPS (TTM).
Time to BUY Virgin Galactic ?! 🚀 BIGGEST Problem SPCE Has 😲 BULLISH SPCE Price Prediction
The Prime Interest Rate | Industrial Stocks List